We are live on ! Find out more
BCAB icon

BioAtla
BCAB

73 hedge funds and large institutions have $208M invested in BioAtla in 2022 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 20 increasing their positions, 22 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

360% more call options, than puts

Call options by funds: $3.34M | Put options by funds: $726K

211% more capital invested

Capital invested by funds: $67.1M → $208M (+$141M)

0.18% more ownership

Funds ownership: 1.31% → 1.49% (+0.18%)

9% less repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 22

4% less funds holding

Funds holding: 76 → 73 (-3)

12% less first-time investments, than exits

New positions opened: 22 | Existing positions closed: 25

Holders
73
Holders Change
-3
Holders Change %
-3.95%
% of All Funds
1.26%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
22
Increased
20
Reduced
22
Closed
25
Calls
$3.34M
Puts
$726K
Net Calls
+$2.61M
Net Calls Change
+$2.67M

Top Buyers

Rank Fund Capital Flow
1
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$13.2M
2
CS
Candriam SCA
Luxembourg
+$10M
3
EAM
Eventide Asset Management
Massachusetts
+$5.2M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
+$5.01M
5
ACA
Avoro Capital Advisors
New York
+$3.76M

Top Sellers

Rank Fund Capital Flow
1
TCM
Tang Capital Management
California
-$9.2M
2
RCM
RA Capital Management
Massachusetts
-$2.94M
3
BBA
Baker Bros. Advisors
New York
-$2.35M
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$1.94M
5
Two Sigma Investments
Two Sigma Investments
New York
-$1.49M
Name Holding Trade Value Shares
Change 		Change in
Stake
UOC
26
UBS O'Connor
Illinois
$862K +$733K +2,240 New
SFI
27
Susquehanna Fundamental Investments
Pennsylvania
$830K +$706K +2,156 New
Goldman Sachs
28
Goldman Sachs
New York
$811K +$183K +559 +36%
Acadian Asset Management
29
Acadian Asset Management
Massachusetts
$765K -$347K -1,061 -35%
Citadel Advisors
30
Citadel Advisors
Florida
$620K -$644K -1,968 -55%
State Street
31
State Street
Massachusetts
$613K +$155K +472 +42%
Northern Trust
32
Northern Trust
Illinois
$553K +$118K +361 +34%
Susquehanna International Group
33
Susquehanna International Group
Pennsylvania
$550K -$331K -1,010 -41%
Bank of America
34
Bank of America
North Carolina
$400K -$982 -3 -0.3%
FAM
35
Formidable Asset Management
Ohio
$318K -$201K -614 -43%
FAM
36
Fred Alger Management
New York
$317K +$269K +823 New
TI
37
Tidal Investments
Wisconsin
$315K -$580K -1,772 -68%
CIC
38
Cornercap Investment Counsel
Georgia
$251K -$97.2K -297 -31%
Millennium Management
39
Millennium Management
New York
$241K -$956K -2,920 -82%
RI
40
Rinkey Investments
California
$226K +$11.8K +36 +8%
Dimensional Fund Advisors
41
Dimensional Fund Advisors
Texas
$207K +$176K +537 New
PP
42
PDT Partners
New York
$189K -$506K -1,547 -76%
BCM
43
Bridgeway Capital Management
Texas
$169K +$144K +440 New
OQS
44
Occudo Quantitative Strategies
Florida
$153K -$163K -498 -56%
Fidelity Investments
45
Fidelity Investments
Massachusetts
$146K -$1.94M -5,917 -94%
CSS
46
Cubist Systematic Strategies
Connecticut
$129K -$101K -308 -48%
BNP Paribas Financial Markets
47
BNP Paribas Financial Markets
France
$125K +$107K +326 New
SSA
48
Schonfeld Strategic Advisors
New York
$115K -$205K -626 -68%
Charles Schwab
49
Charles Schwab
California
$101K -$500K -1,528 -85%
Bank of New York Mellon
50
Bank of New York Mellon
New York
$101K +$86.1K +263 New
1
2
3 4

BCAB Hedge Fund Activity: Q3 2022 in Review

73 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in BioAtla (BCAB) for Q3 2022, worth a combined $208M — up 211% from $67.1M a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of BCAB and 22 opened new positions — a net loss of 3 holders — while 22 trimmed existing stakes and 20 added.

The largest buyer was Janus Henderson Group, adding an estimated $13.2M. The largest seller was Tang Capital Management, cutting an estimated $9.2M.

  • 73 institutional investors held BioAtla (BCAB) as of Q3 2022, down from 76 in Q2 2022.
  • Funds reported $208M of BioAtla stock for Q3 2022, up 211% quarter-over-quarter.
  • 22 funds opened new BioAtla positions in Q3 2022 and 25 closed out, a net change of -3 holders.
  • The largest BioAtla buyer in Q3 2022 was Janus Henderson Group, an estimated $13.2M added.
  • The largest BioAtla seller in Q3 2022 was Tang Capital Management, an estimated $9.2M sold.

Based on aggregated 13F filings for Q3 2022.